Central nervous system toxoplasmosis with an increased proportion of circulating γδ T cells in a patient with hyper-IgM syndrome

Journal of Clinical Immunology

Volumn 18, Issue 4, 1998, Pages 283-290

  Leiva, Lily E ^a,b   Junprasert, Jurairat ^a   Hollenbaugh, Diane ^c   Sorensen, Ricardo U ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

T cells; CD40 ligand; CNS toxoplasmosis; Hyper IgM syndrome

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PYRIMETHAMINE; SULFADIAZINE;

ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HYPERIMMUNOGLOBULINEMIA; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; TOXOPLASMOSIS;

AGING; ANIMALS; ANTIGENS, CD40; BRAIN; CENTRAL NERVOUS SYSTEM INFECTIONS; CHILD; FLOW CYTOMETRY; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOCYTE ACTIVATION; MAGNETIC RESONANCE IMAGING; MALE; T-LYMPHOCYTES; TOXOPLASMA; TOXOPLASMOSIS;

EID: 0031829198     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027337923709     Document Type: Article

References (36)

1. Notarangelo LD, Duse M, Ugazio AG: Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 3:101-122, 1992
2. Conley ME, Larche M, Bonagura VR, Lawton III AR, Buckley RH, Fu SM, Coustan-Smith E, Herrod HG, Campana D: Hyper IgM syndrome associated with defective CD40-mediated B cell activation. J Clin Invest 94:1404-1409, 1994
3. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EAM, Tabone M-D, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Tore A, Jones A, Finn A: Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131:47-54, 1997
4. Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NY, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A: The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 11:4313-4321, 1992
5. Allen RC, Armitage RJ, Conley MA, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Desteche CM, Simoneaux DK, Fanslow WC, Belmont J, Spriggs MK: CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990-993, 1993
6. Notarangelo LD, Peitsch MC: CD40Lbase: A database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today 1996(11):511-516, 1996
7. Grewal IS, Xu J, Flavell RA: Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617-623, 1995
8. Grewal IS, Flavell RA: A central role for CD40 ligand in the regulation of CD4+ T-cell responses. Immunol Today 17:410-414, 1996
9. Grewal IS, Foellmer HG, Grewal KD, Xu J, Hardardottir F, Baron JL, Janeway CA, Flavell RA: Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273:1864-1867, 1996
10. Yang Y, Wilson JM: CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40. Science 273: 1862-1864, 1996
11. Hostoffer RW, Berger M, Clark HT, Schreiber J: Disseminated Histoplasma capsulatum in a patient with hyper IgM immunodeficiency. Pediatrics 94:234-236, 1994
12. Luft BJ, Naot Y, Araujo FG, Stinson EB: Primary and reactivated Toxoplasma infection in patients with cardiac transplants. Ann Intern Med 99:27-31, 1983
13. Luft BJ, Brooks RG, Conley FK, McCabe RE, Remington JS: Toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome. JAMA 252:913-917, 1984
14. Michaels MG, Wald ER, Fricker FJ, Nido PJ, Armitage J: Toxoplasmosis in pediatric recipients of heart transplants. Clin Infect Dis 15:847-851, 1992
15. Israelski DM, Remington JS: Toxoplasmosis in the non-AIDS immunocompromised host. Curr Clin Topics Infect Dis 13:322-356, 1993
16. Khan EA, Correa AG: Toxoplasmosis of the central nervous system in non-human immunodeficiency virus-infected children: Case report and review of the literature. Pediatr Infect Dis J 16:611-618, 1997
17. Hinz T, Wesch D, Friese K, Reckziegel A, Arden B, Kabelitz D: T cell receptor gamma/delta repertoire in HIV-1-infected individuals. Eur J Immunol 24:3044-3049, 1994
18. Ueta C, Tsuyuguchi I, Kawasumi H, Takashima T, Toba H, Kishimoto S: Increase of gamma/delta T cells in hospital workers who are in close contact with tuberculosis patients. Infect Immun 62:5434-5441, 1994
19. Roussilhon C, Agrapart M, Guglielmi P, Bensussan A, Brasseur P, Ballet JJ: Human TcR gamma/delta lymphocyte response on primary exposure to Plasmodium falciparum. Clin Exp Immunol 95:91-97, 1994
20. De Paoli P, Basaglia G, Gennari D, Crovatto M, Modolo ML, Santini G: Phenotypic profile and functional characteristics of human gamma and delta T cells during acute toxoplasmosis. J Clin Microbiol 30:729-731, 1992
21. Scalise F, Gerli R, Castellucci G, Spinozzi F, Fabietti FM, Crupi S, Sensi L: Lymphocytes bearing the gamma/delta T-cell receptor in acute toxoplasmosis. Immunology 76:668-670, 1992
22. Morio T, Nagasawa M, Nonoyama S, Okawa H, Yata J-I: Phenotypic profile and functions of T cell receptor-gamma/delta-bearing cells from patients with primary immunodeficiency syndrome. J Immunol 144:1270-1275, 1990
23. Morio T, Nagasawa M, Yata J-I. Gamma-delta T cells in patients with primary immunodeficiency syndrome: Their function and a possible role in pathogenesis. In Heat-Shock Proteins and Gamma-Delta T Cells, CF Brosnan (ed). New York, Karger, 1992, pp 102-120
24. Aruffo A, Farrington M, Hollenbaugh D, Xu L, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, Ochs HD: The CD40 ligand, pg39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291-300, 1993
25. Callard RE, Armitage RJ, Fanslow WC, Spriggs MK: CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 14:559-564, 1993
26. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ: The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 15:406-410, 1994
27. Conley ME: An evolving view of hyper-IgM syndrome. J Pediatr 131:8-9, 1997
28. Ameratunga R, Lederman HM, Sullivan KE, Ochs HD, Seyama K, French JK, Prestidge R, Marbrood J, Fanslow WC, Winkelstein JA: Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome. J Pediatr 131:147-150, 1997
29. Campos-Neto A, Ovendale P, Bement T, Koppi TA, Fanslow WC, Rossi MA, Alderson MR: Cutting edge: CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J Immunol 160:2037-2041, 1998
30. Haas W, Pereira P, Tonegawa S: Gamma/delta cells. Annu Rev Immunol 11:637-685, 1993
31. Ferrick DA, Schrenzel MD, Mulvania T, Hsieh B, Ferlin WG, Lepper H: Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma/delta T cells in vivo. Nature 373:255-257, 1995
32. Horner AA, Jabara H, Ramesh N, Geha RS: Gamma/delta T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytes. J Exp Med 181:1239-1243, 1995
33. Subauste CS, Chung JY, Do D, Koniaris AH, Hunter CA, Montoya JG, Porcelli S, Remington JS: Preferential activation and expansion of human peripheral blood gamma/delta T cells in response to Toxoplasma gondii in vitro and their cytokine production and cytotoxic activity against T. gondii-infected cells. J Clin Invest 96:610-619, 1995
34. Constant P, Davodeau F, Peyrat M-A, Poquet Y, Puzo G, Bonneville M, Fournie J-J: Stimulation of human gamma/delta T cells by nonpeptidic mycobacterial ligands. Science 264:267-270, 1994
35. Bukowski JF, Morita CT, Brenner MB: Recognition and destruction of virus-infected cells by human gamma/delta CTL. J Immunol 153:5133-5140, 1994
36. Katial RK, Lieberman MM, Muehlbauer SL, Lust JA, Hamilos DL: Gamma/delta T lymphocytosis associated with common variable immunodeficiency. J Clin Immunol 17:34-42, 1997